Dr. Saad is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1092 Old Churchmans Rd
Newark, DE 19713Phone+1 302-472-9880Fax+1 302-472-9614
Summary
- Dr. Theodore Saad is a nephrologist in Newark, DE and is affiliated with multiple hospitals in the area, including Christiana Care, St. Francis Hospital, Select Specialty Hospital-Wilmington, and Union Hospital. He received his medical degree from The University of Pennsylvania School of Medicine in 1984 and has been in practice for 33 years. He is experienced in general nephrology, interventional nephrology, dialysis, and hemodialysis vascular access. He is active in clinical investigation, device and pharmaceutical trials.
Education & Training
- University of Pennsylvania Health SystemFellowship, Nephrology, 1987 - 1989
- University of Pennsylvania Health SystemResidency, Internal Medicine, 1984 - 1987
- Perelman School of Medicine at the University of PennsylvaniaClass of 1984
- Bucknell UniversityBA, Physics, Magna Cum Laude, 1976 - 1980
Certifications & Licensure
- DE State Medical License 1999 - 2025
- MD State Medical License 1999 - 2025
- TX State Medical License 1992 - 2012
- PA State Medical License 1986 - 1996
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Nephrology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
- AOA 1983
Clinical Trials
- The Merit WRAPSODY AV Access Efficacy Study (WAVE) Start of enrollment: 2021 Mar 09
- Study of Efficacy and Safety of LNP023 in Primary IgA Nephropathy Patients Start of enrollment: 2021 Jan 25
- Study Evaluating the Efficacy and Safety of Dose Conversion From a Long-acting Erythropoiesis-stimulating Agent (Mircera®) to Three Times Weekly Oral Vadadustat for the Maintenance Treatment of Anemia in Hemodialysis Subjects Start of enrollment: 2021 Jun 18
- Join now to see all
Publications & Presentations
PubMed
- Rilparencel (Renal Autologous Cell Therapy-REACT®) for Chronic Kidney Disease and Type 1 and Type 2 Diabetes: Phase 2 Trial Design Evaluating Bilateral Kidney Dosing a...Joseph Stavas, Arnold L Silva, Thomas D Wooldridge, Ahmed Aqeel, Theodore Saad
American Journal of Nephrology. 2024-01-01 - 2 citationsDrug-coated balloons and dialysis vascular access: is there light at the end of the tunnel . . .Prabir Roy-Chaudhury, Theodore F. Saad, Scott O. Trerotola
Kidney International. 2021-08-01 - 2 citationsDrug-Coated Balloon Angioplasty in Failing Arteriovenous Fistulas: More Data, Less Clarity.Scott O. Trerotola, Prabir Roy-Chaudhury, Theodore F. Saad
American Journal of Kidney Diseases. 2021-05-08
Authored Content
- Don't Politicize Kidney Patients' Health CareAugust 2019
Professional Memberships
- Member
- Member
- American Society of Diagnostic and Interventional NephrologyMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: